One vocabulary, one place

The mechanism sites share a vocabulary. This index defines the terms once and points to where each is used, so the network reads consistently. Definitions are descriptive framing only — no term here is a recommendation, and pointing to a site is navigation, not a claim.

TermDefinitionUsed on
Hallmark of agingOne of the 12 organizing categories of aging biology (Lopez-Otin et al. 2023). Used descriptively across the network to structure the sites, not as a claim that anything is targeted.see ›
Evidence tierA position on the shared seven-tier scale, from a healthy-aging lifespan RCT (tier 1, empty network-wide) down to in-vitro mechanism (tier 7). Never collapsed into a single score.see ›
Human lifespan RCTA randomized controlled trial with a healthy-aging lifespan endpoint in a healthy-aging population. None exists for any mechanism in this network.see ›
Biomarker endpointA measured surrogate (e.g. telomere length, senescent-cell burden, a functional marker) rather than a clinical outcome or lifespan. A biomarker change is not a clinical outcome.see ›
Healthspan vs lifespanHealthspan is years of good function; lifespan is total years lived. A healthspan or function change, especially in an animal, is not a human lifespan result.see ›
Disease-population outcomeA hard clinical result measured in patients with a disease, not in healthy aging. Real and important, but it is disease treatment, never presented here as a healthy-aging benefit.see ›
Honesty flag (green / amber / grey)The three-colour marker on every site card: green = lifespan RCT (none exist), amber = human data but not a lifespan RCT, grey = animal/mechanism-only or not yet published.see ›
mTOR / nutrient-sensingThe insulin/IGF-1, mTOR, AMPK and sirtuin signaling network that senses nutrients; the deregulated-nutrient-sensing hallmark. Covered by the mtorix site.see ›
Cellular senescence / SASPGrowth-arrested cells that accumulate with age and secrete a pro-inflammatory signal set (the senescence-associated secretory phenotype). Covered by the senesiq site.see ›
SenolyticA compound intended to clear senescent cells (e.g. dasatinib+quercetin, fisetin). Human evidence is pilot / biomarker grade only. Covered by the senesiq site.see ›
Mitochondrial dysfunctionAge-related decline in mitochondrial efficiency and dynamics with increased ROS leakage; a hallmark of aging. Covered by the mitoix site.see ›
Telomere attrition / telomeraseProgressive shortening of chromosome-end caps, and the enzyme that extends them. Telomere length is a contested aging marker. Covered by the teloix site.see ›